Arrowhead Publishers, May 2010, Pages: 261
to Improve R&D
2.4.6 Reduce Healthcare Costs
2.5 PERSONALIZED APPROACH VERSUS CURRENT PRACTICE PARADIGMS
3 OVERVIEW OF PHARMACOGENOMICS: THE SCIENCE BEHIND PERSONALIZEDMEDICINE
3.1 AN INTRODUCTION
TriMark Publications, June 2009, Pages: 244
Fields in Biological Science with the Potential to ImpactPersonalizedMedicine 184 - Abbott Laboratories
- Affymetrix
- Agilent Technologies, Inc.
- Ambry Genetics
- ARCA Biopharma, Inc.
- Asper
Decision Resources, Inc., Nov 2009, Pages: 28
Introduction Successful navigation of the regulatory maze is a prerequisite for companies using biomarkers and diagnostics to advance personalizedmedicine. U.S., European, and Japanese regulators
TriMark Publications, Sep 2010, Pages: 1846
Expression Reagents Markets
- Genomics World Markets
- Microarray Markets
- PersonalizedMedicine
- Pharmacogenomics for Clinical Use and in Drug Development
- Regenerative Medicine Markets
- RNA Interference
Business Insights, March 2008, Pages: 171
. Pharmacogenomics (PGx) embodies the principles of personalizedmedicine by combining pharmacology with genetic information to improve drug safety and efficiency.
The pharma industry is currently applying PGx
Business Insights, Aug 2009, Pages: 141
million in R&D and just over $130 million on sales and marketing since 2004.
Use this report to
- Understand the driving forces shaping personalizedmedicine and how this will impact the current
Business Insights, Sep 2006, Pages: 126
technologies that are enabling personalized healthcare to move into mainstream medicine.
New opportunities in infectious disease testing, molecular oncology and pharmacogenomics are explored in detail
Decision Resources, Inc., March 2009, Pages: 31
The promise of personalizedmedicine is having a profound impact on the healthcare industry. It promises to change the way healthcare is delivered and how drugs and diagnostics are developed. Pharma
Business Insights, Oct 2009, Pages: 141
the market for cancer diagnostics globally. Major developments are likely in both the IVD market and in imaging-based modalities, like computed tomography, with the emphasis being upon the personalizedmedicine approach
Business Insights, Jan 2010, Pages: 151
and diagnostic industry to personalize nutrition and medicine.
Key features of this report
- Identify leading academic groups and companies at the forefront of the nutrigenomic research who will drive
Takeda Pacific, June 2007, Pages: 130
of Biomarkers
The Regulatory Definition of Biomarkers and Tests for Drug R&D
Biomarkers and Tests
Nucleic Acids, Proteins, Profiles and Metabolites
Biomarkers, Pharmacogenomics (PGx) and PersonalizedMedicine
New
Decision Resources, Inc., March 2008, Pages: 42
together effectively to develop more personalizedmedicines. What are the bottlenecks delaying these interactions? What still needs to be done to make this process work better?
- Pharmaceutical companies
Jain PharmaBiotech, Feb 2012, Pages: 864
with diagnostics and will thus play an important role in the development of personalizedmedicine. Biomarkers play a role in use of pharmacogenetics, pharmacogenomics and pharmacoproteomics for development
Business Insights, June 2009, Pages: 114
of pharmacogenomics-based patient management and changing approaches to pharma R&D.
Explore issues including...
Technology is outpacing regulatory guidance on Rx-Dx co-development. Pharma and diagnostic companies
OECD Publishing, Dec 2009, Pages: 132
Pharmacogenetics helps us understand the relationship between an individual’s genetic make-up and the way medicines work for each person. This book reviews the use of pharmacogenetics across all
John Wiley and Sons Ltd, Jan 2010, Pages: 565
. Bridging the Pharmaceutical Shortfall: Informatics approaches to the discovery of Vaccines, Antigens, Epitopes, and Adjuvants (Matthew N. Davies and Darren R. Flower).
11.1. Introduction.
11.2.
Espicom Business Intelligence Ltd, Aug 2010, Pages: 138
for their identification and qualification
Assess the near, mid and long term impacts of biomarkers
Expert opinions from...
Spiros Vamvakas MD, EMEA
Head of Scientific Advice, Human Medicines Special Areas EMEA
Taiyou Research, June 2011, Pages: 430
applications of biotechnology in medicine, pharmacogenomics, pharmaceutical products, genetic testing, gene therapy, cloning, as well as agricultural and other applications are analyzed.
- Industry segmentation
